Smith & Nephew plc
NYSE: SNN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Deepak S Nath
- Employees
- 17,818
- Headquarters
- Watford, United Kingdom
- IPO year
- 1999
- Market cap
- $12.1B
- Website
- https://www.smith-nephew.com
Loading SNN…
Loading profile data…Frequently asked questions about SNN
What does Smith & Nephew plc (SNN) do?
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement...
Where does SNN trade?
Smith & Nephew plc (SNN) trades on the New York Stock Exchange.
What sector is SNN in?
Smith & Nephew plc (SNN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Smith & Nephew plc?
Deepak S Nath is the chief executive officer of Smith & Nephew plc (SNN).
Where is Smith & Nephew plc headquartered?
Smith & Nephew plc is headquartered in United Kingdom.
Does SNN pay a dividend?
Yes — Smith & Nephew plc (SNN) paid a trailing twelve-month dividend of USD 0.78 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SNN go public?
Smith & Nephew plc (SNN) completed its initial public offering in 1999.